Skip to content

Growth Hormone Fragment 176-191

HGH Fragment 176-191 Australia

Everything researchers need to know about HGH Fragment 176-191 — mechanism, published dosing protocols, side effect profiles, reconstitution, and how to source third-party tested HGH Fragment 176-191 in Australia.

Quick facts

  • Also known as: Growth Hormone Fragment
  • Form: Lyophilised powder (>99% purity)
  • Variants: 5 mg
  • 🇦🇺 3–5 business days
HPLC/MS VerifiedCOA DocumentedAU Same-Day DispatchPayID AcceptedHPLC/MS VerifiedCOA DocumentedAU Same-Day DispatchPayID AcceptedHPLC/MS VerifiedCOA DocumentedAU Same-Day DispatchPayID Accepted

Overview

What Is HGH Fragment 176-191?

HGH Fragment 176-191 is the C-terminal fragment of human growth hormone, encompassing amino acids 176-191. Unlike AOD-9604, this is the unmodified natural fragment. Research focuses on its lipolytic activity independent of the growth-promoting and diabetogenic effects of full-length hGH.

Also known as Growth Hormone Fragment, HGH Fragment 176-191 is supplied as a lyophilised research peptide for laboratory use only. Studies indicate HGH Frag 176-191 stimulates lipolysis approximately 12.5 times more potently than full-length hGH in adipose tissue assays. It does not compete for the GH receptor and does not affect IGF-1 or insulin levels. Research suggests its mechanism involves beta-3 adrenergic receptor interaction and hormone-sensitive lipase activation.

What Is HGH Fragment 176-191?
HGH Fragment 176-191 mechanism diagram

Mechanism

How HGH Fragment 176-191 Works — Research Mechanism

Studies indicate HGH Frag 176-191 stimulates lipolysis approximately 12.5 times more potently than full-length hGH in adipose tissue assays. It does not compete for the GH receptor and does not affect IGF-1 or insulin levels. Research suggests its mechanism involves beta-3 adrenergic receptor interaction and hormone-sensitive lipase activation.

  • C-terminal fragment of human growth hormone (amino acids 176-191)
  • ~12.5× more potent lipolysis than full-length hGH in adipose assays
  • Does not compete for GH receptor or affect IGF-1 levels
  • Beta-3 adrenergic receptor and hormone-sensitive lipase activation
  • Distinct from AOD-9604 (unmodified natural fragment)

Research reference

HGH Fragment 176-191 Dosage — Published Research Protocols

The following reference points are drawn from published research literature. These figures are provided for research reference only and do not constitute dosing recommendations. HGH Fragment 176-191 is sold strictly for laboratory research use.

Protocol tierPublished research detail
Research referencePublished literature varies by model and endpoint — consult primary sources for protocol-specific dosing in laboratory settings
Administration routeSubcutaneous injection is most common in published peptide research protocols
FrequencyDosing frequency depends on compound half-life and research design — daily to weekly intervals reported in literature
Available vial sizes5 mg — select based on your laboratory protocol requirements
TitrationMany research protocols start at lower doses and escalate to assess receptor response and tolerability in models

Research use only: FOR LABORATORY RESEARCH USE ONLY. Not for human consumption, injection, or therapeutic use. All products are sold strictly as research chemicals. By purchasing, you confirm you are 18+ and agree to use products solely for legitimate research purposes.

Safety research

HGH Fragment 176-191 Side Effects — Research Findings

Side effect profiles documented in published HGH Fragment 176-191 research depend on dose, route of administration, and model system. The following are commonly reported findings from research literature — not from personal use contexts.

  • Injection site reactions common to peptide administration routes
  • Transient water retention reported in some GH-axis research models
  • Headache and mild fatigue documented in GHRH/GHRP combination studies
  • Effects generally resolve with dose adjustment in published protocols

Handling

Reconstituting HGH Fragment 176-191

HGH Fragment 176-191 is supplied as a lyophilised powder and must be reconstituted before use in laboratory protocols. Use bacteriostatic water (0.9% benzyl alcohol) for multi-dose vials. Inject diluent slowly down the inside wall of the vial — do not shake vigorously.

Bacteriostatic water is available from EvoPeak. Store reconstituted peptide at 2–8°C and lyophilised powder at −20°C.

Shop bacteriostatic water

Australia

How to Get HGH Fragment 176-191 in Australia

Researchers in Australia can source HGH Fragment 176-191 through EvoPeak — a local supplier offering third-party tested research compounds with batch-specific COA documentation and domestic shipping.

  1. 1

    Browse HGH Fragment 176-191 variants (5 mg) on the EvoPeak product page

  2. 2

    Review the certificate of analysis (COA) for HPLC purity and mass spectrometry identity verification

  3. 3

    Select your vial size and add to cart — prices include GST with same-day Australian dispatch

  4. 4

    Receive your order with batch-specific quality documentation for laboratory traceability

Quality Standard

Research compounds need evidence, not guesswork.

Every shopping path leads back to the same core standard: research-use positioning, third-party quality signals, transparent documentation, and careful handling guidance.

HPLC/MS verified

Purity and identity checks support confident compound selection for controlled research.

Endotoxin screened

Quality review extends beyond purity so researchers can evaluate handling risk.

Batch documentation

COA-first product pages keep quality signals close to every purchase decision.

Australia shipped

Local fulfilment keeps delivery predictable for Australian research customers.

FAQ

HGH Fragment 176-191 — Common Questions

What is HGH Fragment 176-191?

C-terminal fragment of hGH for lipolysis-specific research. HGH Fragment 176-191 is the C-terminal fragment of human growth hormone, encompassing amino acids 176-191. Unlike AOD-9604, this is the unmodified natural fragment. Research focuses on its lipolytic a… It is supplied for laboratory research use only.

What is the HGH Fragment 176-191 dosage used in research?

Published research uses varying doses depending on the model and endpoint. EvoPeak supplies 5 mg vials. All dosage information is for research reference only and does not constitute recommendations.

What are the side effects of HGH Fragment 176-191?

Side effect profiles in published research depend on dose, route, and model system. Consult primary literature for compound-specific findings. All information is drawn from research contexts, not personal use.

Can I buy HGH Fragment 176-191 in Australia?

Yes. EvoPeak supplies research-grade HGH Fragment 176-191 to Australian researchers with HPLC/MS verification, batch-specific COA documentation, and domestic shipping. Products are for laboratory research use only.

How do I get HGH Fragment 176-191 in Australia?

Order from the EvoPeak shop page, select your vial size, review the COA, and checkout with local Australian fulfilment.

How do I reconstitute HGH Fragment 176-191?

HGH Fragment 176-191 is supplied as lyophilised powder. Reconstitute with bacteriostatic water, inject diluent slowly down the vial wall without shaking, and store at 2–8°C once reconstituted. Bacteriostatic water is available from EvoPeak.

What purity standard does EvoPeak HGH Fragment 176-191 meet?

Every batch undergoes HPLC purity analysis (targeting >99%), mass spectrometry identity verification, and endotoxin screening. Batch-specific COAs are available on the product page.

Is hgh fragment 176-191 peptide the same as Growth Hormone Fragment?

HGH Fragment 176-191 is also known as Growth Hormone Fragment. Both refer to the same research compound supplied by EvoPeak.

Ready to order HGH Fragment 176-191?

Third-party HPLC/MS tested with batch-specific COA documentation. Shipped from Australia for laboratory research use only.